MAIA Biotechnology raises $2.25M via private placement to fund Phase II trial THIO-101. Learn more about the investment opportunity and latest updates.
MAIA Biotechnology announces $2.25 million private placement
MAIA Biotechnology raises $2.25M via private placement to fund Phase II trial THIO-101. Learn more about the investment opportunity and latest updates.